Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes

Journal of Virology

Volumn 87, Issue 23, 2013, Pages 13020-13028

  Hodin, Theresa L ^a   Najrana, Tanbir ^a   Yates, John L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; PROTEIN ORIP; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL STRAIN HEK293; CHROMOSOME; CONTROLLED STUDY; DNA BINDING; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; VIRUS REPLICATION; WILD TYPE;

CELL CYCLE; CELL LINE; CELL NUCLEUS; CHROMOSOMES, HUMAN; DNA REPLICATION; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HUMANS; ORIGIN RECOGNITION COMPLEX; PLASMIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; REPLICATION ORIGIN; VIRUS REPLICATION;

EID: 84887183280     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01606-13     Document Type: Article

References (54)

1. Ganem D. 2007. Kaposi's sarcoma-associated herpesvirus, p 2847-2888. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Kieff ED, Rickinson AB. 2007. Epstein-Barr virus and its replication, p 2603-2654. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Ballestas ME, Kaye KM. 2011. The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol. 6:1399-1413.
4. Hammerschmidt W, Sugden B. 2006. Epstein-Barr virus, p 187-706. In Depamphilis ML (ed), DNA replication and human disease. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
5. Grundhoff A, Ganem D. 2003. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J. Virol. 77:2779-2783.
6. Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Joukov V, Walter JC, Luger K, Kaye KM. 2006. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311:856-861.
7. Marechal V, Dehee A, Chikhi-Brachet R, Piolot T, Coppey-Moisan M, Nicolas JC. 1999. Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J. Virol. 73:4385-4392.
8. Middleton T, Sugden B. 1994. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J. Virol. 68:4067-4071.
9. Hung SC, Kang MS, Kieff E. 2001. Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc. Natl. Acad. Sci. U.S.A. 98:1865-1870.
10. Kanda T, Otter M, Wahl GM. 2001. Coupling of mitotic chromosome tethering and replication competence in Epstein-Barr virus-based plasmids. Mol. Cell. Biol. 21:3576-3588.
11. Gahn TA, Schildkraut CL. 1989. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell 58:527-535.
12. Harrison S, Fisenne K, Hearing J. 1994. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication. J. Virol. 68:1913-1925.
13. Wysokenski DA, Yates JL. 1989. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol. 63:2657-2666.
14. Norio P, Schildkraut CL, Yates JL. 2000. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines. J. Virol. 74:8563-8574.
15. Bashaw JM, Yates JL. 2001. Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA. J. Virol. 75:10603-10611.
16. Yates JL, Camiolo SM, Bashaw JM. 2000. The minimal replicator of Epstein-Barr virus oriP. J. Virol. 74:4512-4522.
17. Deng Z, Atanasiu C, Burg JS, Broccoli D, Lieberman PM. 2003. Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J. Virol. 77:11992-12001.
18. Deng Z, Lezina L, Chen CJ, Shtivelband S, So W, Lieberman PM. 2002. Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Mol. Cell 9:493-503.
19. Sears J, Kolman J, Wahl GM, Aiyar A. 2003. Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1. J. Virol. 77:11767-11780.
20. Sears J, Ujihara M, Wong S, Ott C, Aiyar A. 2004. The amino terminus of Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J. Virol. 78:11487-11505.
21. Aras S, Singh G, Johnston K, Foster T, Aiyar A. 2009. Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1. PLoS Pathog. 5:e1000469. doi:10.1371/journal.ppat.1000469.
22. Lin A, Wang S, Nguyen T, Shire K, Frappier L. 2008. The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4. J. Virol. 82:12009-12019.
23. Norseen J, Johnson FB, Lieberman PM. 2009. Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment. J. Virol. 83:10336-10346.
24. Norseen J, Thomae A, Sridharan V, Aiyar A, Schepers A, Lieberman PM. 2008. RNA-dependent recruitment of the origin recognition complex. EMBO J. 27:3024-3035.
25. Mackey D, Sugden B. 1999. The linking regions of EBNA1 are essential for its support of replication and transcription. Mol. Cell. Biol. 19:3349-3359.
26. Wu H, Kapoor P, Frappier L. 2002. Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J. Virol. 76:2480-2490.
27. Yates JL, Warren N, Sugden B. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-815.
28. Sugden B, Marsh K, Yates J. 1985. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol. Cell. Biol. 5:410-413.
29. Yates JL, Camiolo SM. 1988. Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cells 6:197-205.
30. Kirchmaier AL, Sugden B. 1997. Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J. Virol. 71:1766-1775.
31. Kennedy G, Sugden B. 2003. EBNA-1, a bifunctional transcriptional activator. Mol. Cell. Biol. 23:6901-6908.
32. Frost E, Williams J. 1978. Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue. Virology 91:39-50.
33. Belgrader P, Cheng J, Zhou X, Stephenson LS, Maquat LE. 1994. Mammalian nonsense codons can be cis effectors of nuclear mRNA halflife. Mol. Cell. Biol. 14:8219-8228.
34. Krysan PJ, Haase SB, Calos MP. 1989. Isolation of human sequences that replicate autonomously in human cells. Mol. Cell. Biol. 9:1026-1033.
35. Leight ER, Sugden B. 2001. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon. J. Virol. 75:10709-10720.
36. Barbera AJ, Ballestas ME, Kaye KM. 2004. The Kaposi's sarcomaassociated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association,DNA replication, and episome persistence. J. Virol. 78:294-301.
37. Hu J, Garber AC, Renne R. 2002. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol. 76:11677-11687.
38. Roussel L, Erard M, Cayrol C, Girard JP. 2008. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2AH2B acidic pocket. EMBO Rep. 9:1006-1012.
39. Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L. 2003. Protein interaction domains of the ubiquitin-specific protease, USP7/ HAUSP. J. Biol. Chem. 278:47753-47761.
40. Kang MS, Lee EK, Soni V, Lewis TA, Koehler AN, Srinivasan V, Kieff E. 2011. Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance. J. Virol. 85:2859-2868.
41. Sivachandran N, Cao JY, Frappier L. 2010. Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies. J. Virol. 84:11113-11123.
42. Reisman D, Yates J, Sugden B. 1985. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5:1822-1832.
43. Lechardeur D, Sohn KJ, Haardt M, Joshi PB, Monck M, Graham RW, Beatty B, Squire J, O'Brodovich H, Lukacs GL. 1999. Metabolic instability of plasmid DNA in the cytosol:a potential barrier to gene transfer. Gene Ther. 6:482-497.
44. Wang CY, Sugden B. 2008. Identifying a property of origins of DNA synthesis required to support plasmids stably in human cells. Proc. Natl. Acad. Sci. U.S.A. 105:9639-9644.
45. Thomae AW, Pich D, Brocher J, Spindler MP, Berens C, Hock R, Hammerschmidt W, Schepers A. 2008. Interaction between HMGA1a and the origin recognition complex creates site-specific replication origins. Proc. Natl. Acad. Sci. U.S.A. 105:1692-1697.
46. Moriyama K, Yoshizawa-Sugata N, Obuse C, Tsurimoto T, Masai H. 2012. Epstein-Barr nuclear antigen 1 (EBNA1)-dependent recruitment of origin recognition complex (Orc) on oriP of Epstein-Barr virus with purified proteins:stimulation by Cdc6 through its direct interaction with EBNA1. J. Biol. Chem. 287:23977-23994.
47. Schepers A, Ritzi M, Bousset K, Kremmer E, Yates JL, Harwood J, Diffley JFX, Hammerschmidt W. 2001. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J. 20:4588-4602.
48. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
49. Picken RN, Yang HL. 1987. The integration of HPV-18 into HeLa cells has involved duplication of part of the viral genome as well as human DNA flanking sequences. Nucleic Acids Res. 15:10068. doi:10.1093/nar/15.23.10068.
50. McNairn AJ, Okuno Y, Misteli T, Gilbert DM. 2005. Chinese hamster ORC subunits dynamically associate with chromatin throughout the cellcycle. Exp. Cell Res. 308:345-356.
51. Gilbert DM, Stillman B. 2006. DNA replication and nuclear architecture, p 179-196. In De Pamphilis ML (ed),DNA replication and human disease. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
52. Ma H, Samarabandu J, Devdhar RS, Acharya R, Cheng PC, Meng C, Berezney R. 1998. Spatial and temporal dynamics of DNA replication sites in mammalian cells. J. Cell Biol. 143:1415-1425.
53. Maya-Mendoza A, Olivares-Chauvet P, Shaw A, Jackson DA. 2010. S phase progression in human cells is dictated by the genetic continuity of DNA foci. PLoS Genet. 6:e1000900. doi:10.1371/journal.pgen.1000900.
54. Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD. 1991. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 65:1466-1478.